Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Four patients with a type of rickets and hair loss had different mutations in their vitamin D receptor gene, causing it to not work properly.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Bmpr2 and Acvr2a receptors are crucial for hair retention and color.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

JAK inhibitors offer new hope for treating severe alopecia areata.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

These new skin treatments are safer and more effective with minimal side effects.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Tofacitinib taken by mouth helps treat hair loss in children.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.